[EN] NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS<br/>[FR] NOUVELLE UTILISATION DES ANTAGONISTES DE LA PROSTAGLANDINE E2
申请人:FUJISAWA PHARMACEUTICAL CO
公开号:WO2000016760A2
公开(公告)日:2000-03-30
Prostaglandin E2 receptor blockets, particularly EP4 receptor blocker, have diuretic activity with a various characteristics such as a lower kaluretic activity relative to natriuretic effect, a larger phosphorus excretion, or the like. Therefore, they are useful for preparation of medicament indicated treating or preventing various edema, hypertension, premenstrual tension, urinary calculus, oliguria, hyperphosphaturia, or the like.